Drugs and Devices

FDA approves new injectable drug for schizophrenia

On Oct. 6, the U.S. Food and Drug Administration (FDA) approved Aristada (aripiprazole lauroxil) extended-release injection to treat adults with schizophrenia. Read more 


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares